Related Experiment Video
Updated: Jan 29, 2026

Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle
Published on: February 1, 2017
Hepatitis A immunity in Yozgat, Turkey
Çigdem Kader1, Ayse Yesim Göçmen, Münire Islak Demir
1Associate Professor Çigdem Kader, Department of Infectious Diseases and Clinical Microbiology,, Bozok Universitesi,, Yozgat 66200, Turkey, T: +903542127060, dr_cigdemtr@ yahoo.com, ORCID: http://orcid. org/0000-0003-3325-4587.
Background:
Since routine immunization could change the epidemiological profile of hepatitis A virus (HAV) infection in the future, it is important to determine the baseline immunity to HAV across Turkey.
Objective:
The aim of this study was to determine the seroprevalence of hepatitis A among individuals 6 years of age and older in Yozgat, Turkey.
Design:
Cross-sectional.
Setting:
Community in central region of Turkey.
Patients And Methods:
Questionnaires and blood specimens were collected and the presence of hepatitis A IgG antibodies against hepatitis A virus was determined quantitatively by ELISA.
Main Outcome Measures:
The rates of hepatitis A immunity by age group.
Sample Size:
1862.
Results:
Immunity to hepatitis A was 79.1% (n=1473). The mean (SD) age was 17.1 (14.7) years in the nonimmune group and 37.8 (19.5) years in the immune group (P less than .001), and immunity increased with age. No significant difference in immunity rate was detected between gen.ders in children and adults. The seropositivity rate for subjects ages 6-19 years was lower than in subjects aged 20-96 years (52.2% versus 93.9%; P less than .001).
Conclusion:
A catch-up vaccination program is needed for persons aged 6-19 years in Yozgat.
Limitations:
Single region data which can not be generalized. For this reason, a multi-centered study that can reflect the whole country is recommended.
Conflict Of Interest:
None.
Related Concept Videos
What is the Immune System?
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Hepatic Portal System
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
Humoral Immune Responses
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Hepatic Drug Excretion: Influencing Factors

